迈普医学
(301033)
| 流通市值：30.21亿 | | | 总市值：35.94亿 |
| 流通股本：5638.68万 | | | 总股本：6708.27万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 189,801,626.51 | 78,362,845.65 | 368,830,564.59 | 249,228,235.32 |
| 营业收入 | 189,801,626.51 | 78,362,845.65 | 368,830,564.59 | 249,228,235.32 |
| 二、营业总成本 | 128,608,088.16 | 57,213,511.8 | 255,227,189.08 | 170,015,989.07 |
| 营业成本 | 39,929,561.54 | 16,639,943.57 | 72,924,429.61 | 47,688,073.55 |
| 税金及附加 | 2,959,981.01 | 1,069,621.35 | 6,746,492.02 | 4,645,903.4 |
| 销售费用 | 31,163,771.42 | 13,900,058.72 | 66,461,330.41 | 44,228,490.91 |
| 管理费用 | 34,517,581.35 | 15,870,550.3 | 72,954,855.91 | 49,001,203.54 |
| 研发费用 | 18,246,698.91 | 8,807,395.01 | 36,961,839.76 | 25,760,728.67 |
| 财务费用 | 1,790,493.93 | 925,942.85 | -821,758.63 | -1,308,411 |
| 其中:利息费用 | 82,130.85 | - | 19,718.01 | 18,522.03 |
| 其中:利息收入 | 761,503.93 | 313,130.44 | 1,582,619.93 | 1,293,322.68 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 291,865.26 | 232,344.82 | 185,028.55 | -123,542.42 |
| 加:投资收益 | 1,711,902.97 | 882,847.76 | 2,938,077.08 | 2,368,792.54 |
| 资产处置收益 | - | - | 6,437.07 | 6,437.07 |
| 资产减值损失(新) | -925,993.42 | -504,515.91 | -2,681,608.94 | -128,571.35 |
| 信用减值损失(新) | -80,638.51 | -5,140.45 | -195,808.27 | 69,926.32 |
| 其他收益 | 4,946,786.04 | 2,008,680.8 | 14,154,054.2 | 7,575,651.64 |
| 四、营业利润 | 67,137,460.69 | 23,763,550.87 | 128,009,555.2 | 88,980,940.05 |
| 加:营业外收入 | 5,000.34 | 5,000.34 | 1,620,980.12 | 1,644,098.27 |
| 减:营业外支出 | 577,762.06 | 2,538.61 | 3,458,136.45 | 2,846,273.73 |
| 五、利润总额 | 66,564,698.97 | 23,766,012.6 | 126,172,398.87 | 87,778,764.59 |
| 减:所得税费用 | 9,984,165.4 | 3,050,630.48 | 13,043,960.35 | 11,924,727.75 |
| 六、净利润 | 56,580,533.57 | 20,715,382.12 | 113,128,438.52 | 75,854,036.84 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 56,580,533.57 | 20,715,382.12 | 113,128,438.52 | 75,854,036.84 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 56,580,533.57 | 20,715,382.12 | 113,128,438.52 | 75,854,036.84 |
| 扣除非经常损益后的净利润 | 53,937,463.57 | 19,525,648.41 | 105,438,127.51 | 72,791,913.75 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.85 | 0.31 | 1.71 | 1.15 |
| (二)稀释每股收益 | 0.84 | 0.31 | 1.69 | 1.14 |
| 八、其他综合收益 | -88,615.72 | -67,015.5 | 75,537.46 | 100,175.2 |
| 归属于母公司股东的其他综合收益 | -88,615.72 | -67,015.5 | 75,537.46 | 100,175.2 |
| 九、综合收益总额 | 56,491,917.85 | 20,648,366.62 | 113,203,975.98 | 75,954,212.04 |
| 归属于母公司股东的综合收益总额 | 56,491,917.85 | 20,648,366.62 | 113,203,975.98 | 75,954,212.04 |
| 公告日期 | 2026-08-21 | 2026-04-28 | 2026-04-28 | 2025-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |